Starpharma Holdings Ltd Signs Research Agreement With Unilever For Dendrimer Technology

Published: Apr 07, 2008

Perth, Apr 7, 2008 (ABN Newswire) - Starpharma Holdings Ltd (ASX:SPL)(OTCQX: SPHRY) today announced the signing of an agreement with Unilever, to co-develop a research tool using Starpharma's Priostar(R) dendrimer technology. An undisclosed fee is payable to Starpharma's US subsidiary DNT Inc as part of the arrangement.

Back to news